Plasmabiotics was created in 2011 by Daniel Vinteler with the aim of revolutionising endoscope disinfection methods. Instead of washing endoscopes with a powerful and harmful detergent, the company proposed to “gas” the bacteria in the device using a plasma gas.
Several companies had already addressed this problem, including Absys financed by Emertec in 2000. But to no avail. Despite the risks, CapDecisif Management decided to invest in April 2012.
After several unsuccessful attempts over a three-year period, it was time to face facts: the technology was not as efficient as the “gold standard” liquid version. The original project had to be abandoned.
But no one had counted on Daniel’s ability to bounce back. As a result of working extensively with the hospital teams in charge of maintaining and storing endoscopes, he realised that once washed the damp endoscopes had a nasty habit of rapidly become contaminated with bacteria again. With this in mind, he converted his disinfection apparatus into a drying apparatus, and as a result managed to extend the endoscopes’ duration of use by several days.
Lots of hospitals quickly equipped themselves with the device, piquing the interest of several manufacturers, including Pentax, which decided to buy the company in 2018 thus offering CapDecisif a great opportunity to exit having made a net 3.6x profit.